questionsmedicales.fr
Établissements, main d'oeuvre et services de soins de santé
Établissements de santé
Unités hospitalières
Unités de soins intensifs
Unités de soins intensifs cardiaques
Unités de soins intensifs cardiaques : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Unités de soins intensifs cardiaques : Questions médicales les plus fréquentes",
"headline": "Unités de soins intensifs cardiaques : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Unités de soins intensifs cardiaques : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-02",
"dateModified": "2025-02-27",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Unités de soins intensifs cardiaques"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Unités de soins intensifs",
"url": "https://questionsmedicales.fr/mesh/D007362",
"about": {
"@type": "MedicalCondition",
"name": "Unités de soins intensifs",
"code": {
"@type": "MedicalCode",
"code": "D007362",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N02.278.388.493"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Unités de soins intensifs cardiaques",
"alternateName": "Coronary Care Units",
"code": {
"@type": "MedicalCode",
"code": "D003325",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "İbrahim Ersoy",
"url": "https://questionsmedicales.fr/author/%C4%B0brahim%20Ersoy",
"affiliation": {
"@type": "Organization",
"name": "Kepez State Hospital, Department of Cardiology - Antalya, Turkey."
}
},
{
"@type": "Person",
"name": "Gökay Taylan",
"url": "https://questionsmedicales.fr/author/G%C3%B6kay%20Taylan",
"affiliation": {
"@type": "Organization",
"name": "Department of Cardiology, Trakya University Faculty of Medicine, Edirne, Türkiye."
}
},
{
"@type": "Person",
"name": "Fatih Kahraman",
"url": "https://questionsmedicales.fr/author/Fatih%20Kahraman",
"affiliation": {
"@type": "Organization",
"name": "Department of Cardiology, Kütahya Evliya Çelebi Training and Research Hospital, Kütahya, Türkiye."
}
},
{
"@type": "Person",
"name": "Ahmet Seyda Yılmaz",
"url": "https://questionsmedicales.fr/author/Ahmet%20Seyda%20Y%C4%B1lmaz",
"affiliation": {
"@type": "Organization",
"name": "Department of Cardiology, Recep Tayyip Erdoğan University Faculty of Medicine, Rize, Türkiye."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Targeting Epidermal Growth Factor Receptor for Cancer Treatment: Abolishing Both Kinase-Dependent and Kinase-Independent Functions of the Receptor.",
"datePublished": "2023-06-20",
"url": "https://questionsmedicales.fr/article/37339882",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1124/pharmrev.123.000906"
}
},
{
"@type": "ScholarlyArticle",
"name": "Inhibition of Epidermal Growth Factor Receptor Signaling by Antisense Oligonucleotides as a Novel Approach to Epidermal Growth Factor Receptor Inhibition.",
"datePublished": "2022-07-20",
"url": "https://questionsmedicales.fr/article/35861718",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1089/nat.2021.0101"
}
},
{
"@type": "ScholarlyArticle",
"name": "Recent findings on the impact of ErbB receptors status on prognosis and therapy of head and neck squamous cell carcinoma.",
"datePublished": "2023-02-02",
"url": "https://questionsmedicales.fr/article/36817764",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fmed.2023.1066021"
}
},
{
"@type": "ScholarlyArticle",
"name": "The epidermal growth factor receptor in healthy pregnancy and preeclampsia.",
"datePublished": "2022-12-07",
"url": "https://questionsmedicales.fr/article/36197759",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1530/JME-22-0105"
}
},
{
"@type": "ScholarlyArticle",
"name": "Control of cell metabolism by the epidermal growth factor receptor.",
"datePublished": "2022-09-09",
"url": "https://questionsmedicales.fr/article/36089077",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.bbamcr.2022.119359"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Établissements, main d'oeuvre et services de soins de santé",
"item": "https://questionsmedicales.fr/mesh/D005159"
},
{
"@type": "ListItem",
"position": 3,
"name": "Établissements de santé",
"item": "https://questionsmedicales.fr/mesh/D006268"
},
{
"@type": "ListItem",
"position": 4,
"name": "Unités hospitalières",
"item": "https://questionsmedicales.fr/mesh/D006757"
},
{
"@type": "ListItem",
"position": 5,
"name": "Unités de soins intensifs",
"item": "https://questionsmedicales.fr/mesh/D007362"
},
{
"@type": "ListItem",
"position": 6,
"name": "Unités de soins intensifs cardiaques",
"item": "https://questionsmedicales.fr/mesh/D003325"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Unités de soins intensifs cardiaques - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Unités de soins intensifs cardiaques",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-13",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Unités de soins intensifs cardiaques",
"description": "Comment diagnostiquer une crise cardiaque ?\nQuels tests sont effectués en USIC ?\nQu'est-ce qu'un angor instable ?\nComment évaluer l'insuffisance cardiaque ?\nQuels sont les signes d'une arythmie ?",
"url": "https://questionsmedicales.fr/mesh/D003325?mesh_terms=ErbB+Receptors&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Unités de soins intensifs cardiaques",
"description": "Quels sont les symptômes d'une crise cardiaque ?\nComment reconnaître un AVC lié au cœur ?\nQuels symptômes indiquent une insuffisance cardiaque ?\nQuels signes d'alerte pour une arythmie ?\nQuels symptômes d'une embolie pulmonaire ?",
"url": "https://questionsmedicales.fr/mesh/D003325?mesh_terms=ErbB+Receptors&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Unités de soins intensifs cardiaques",
"description": "Comment prévenir les maladies cardiaques ?\nQuel rôle de l'exercice dans la prévention ?\nComment gérer le stress pour le cœur ?\nQuel impact de l'alimentation sur le cœur ?\nPourquoi éviter le tabac pour le cœur ?",
"url": "https://questionsmedicales.fr/mesh/D003325?mesh_terms=ErbB+Receptors&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Unités de soins intensifs cardiaques",
"description": "Quels traitements en USIC pour une crise cardiaque ?\nComment traiter l'insuffisance cardiaque ?\nQuels médicaments pour l'arythmie ?\nQuelles interventions pour l'angor instable ?\nQuel rôle des défibrillateurs en USIC ?",
"url": "https://questionsmedicales.fr/mesh/D003325?mesh_terms=ErbB+Receptors&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Unités de soins intensifs cardiaques",
"description": "Quelles complications d'une crise cardiaque ?\nQuels risques après une chirurgie cardiaque ?\nComment l'insuffisance cardiaque peut-elle évoluer ?\nQuelles sont les complications des arythmies ?\nQuels effets secondaires des médicaments cardiaques ?",
"url": "https://questionsmedicales.fr/mesh/D003325?mesh_terms=ErbB+Receptors&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Unités de soins intensifs cardiaques",
"description": "Quels sont les principaux facteurs de risque cardiaque ?\nQuel rôle de l'âge dans les maladies cardiaques ?\nComment le cholestérol affecte-t-il le cœur ?\nQuel impact du diabète sur le cœur ?\nComment le stress influence-t-il le cœur ?",
"url": "https://questionsmedicales.fr/mesh/D003325?mesh_terms=ErbB+Receptors&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une crise cardiaque ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un électrocardiogramme (ECG) et des tests sanguins sont utilisés pour diagnostiquer une crise cardiaque."
}
},
{
"@type": "Question",
"name": "Quels tests sont effectués en USIC ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent ECG, échocardiogramme, et surveillance continue des signes vitaux."
}
},
{
"@type": "Question",
"name": "Qu'est-ce qu'un angor instable ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'angor instable est une douleur thoracique due à une réduction du flux sanguin vers le cœur."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'insuffisance cardiaque ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'insuffisance cardiaque est évaluée par des tests d'imagerie et des biomarqueurs sanguins."
}
},
{
"@type": "Question",
"name": "Quels sont les signes d'une arythmie ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent des palpitations, des étourdissements et des douleurs thoraciques."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une crise cardiaque ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent douleur thoracique, essoufflement, et transpiration excessive."
}
},
{
"@type": "Question",
"name": "Comment reconnaître un AVC lié au cœur ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent une faiblesse d'un côté du corps, des troubles de la parole et des maux de tête."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une insuffisance cardiaque ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fatigue, œdème, et essoufflement lors d'activités normales."
}
},
{
"@type": "Question",
"name": "Quels signes d'alerte pour une arythmie ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent des palpitations, des évanouissements, et des douleurs thoraciques."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'une embolie pulmonaire ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent douleur thoracique aiguë, essoufflement soudain, et toux avec sang."
}
},
{
"@type": "Question",
"name": "Comment prévenir les maladies cardiaques ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Adopter un mode de vie sain, contrôler la pression artérielle et éviter le tabac."
}
},
{
"@type": "Question",
"name": "Quel rôle de l'exercice dans la prévention ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'exercice régulier aide à maintenir un cœur sain et à réduire les facteurs de risque."
}
},
{
"@type": "Question",
"name": "Comment gérer le stress pour le cœur ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des techniques de gestion du stress comme la méditation peuvent réduire les risques cardiaques."
}
},
{
"@type": "Question",
"name": "Quel impact de l'alimentation sur le cœur ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée riche en fruits, légumes et oméga-3 protège le cœur."
}
},
{
"@type": "Question",
"name": "Pourquoi éviter le tabac pour le cœur ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le tabac augmente le risque de maladies cardiaques et d'accidents vasculaires cérébraux."
}
},
{
"@type": "Question",
"name": "Quels traitements en USIC pour une crise cardiaque ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des médicaments, angioplastie, et parfois chirurgie de pontage."
}
},
{
"@type": "Question",
"name": "Comment traiter l'insuffisance cardiaque ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement comprend des médicaments, des changements de mode de vie, et parfois des dispositifs implantables."
}
},
{
"@type": "Question",
"name": "Quels médicaments pour l'arythmie ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les médicaments antiarythmiques, bêtabloquants, et anticoagulants sont souvent prescrits."
}
},
{
"@type": "Question",
"name": "Quelles interventions pour l'angor instable ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les interventions incluent des médicaments, angioplastie, et éventuellement une chirurgie."
}
},
{
"@type": "Question",
"name": "Quel rôle des défibrillateurs en USIC ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les défibrillateurs sont utilisés pour traiter les arythmies potentiellement mortelles."
}
},
{
"@type": "Question",
"name": "Quelles complications d'une crise cardiaque ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent l'insuffisance cardiaque, les arythmies, et le choc cardiogénique."
}
},
{
"@type": "Question",
"name": "Quels risques après une chirurgie cardiaque ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les risques incluent infections, saignements, et complications respiratoires."
}
},
{
"@type": "Question",
"name": "Comment l'insuffisance cardiaque peut-elle évoluer ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut s'aggraver, entraînant des hospitalisations fréquentes et une qualité de vie réduite."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications des arythmies ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les arythmies peuvent entraîner des AVC, des syncopes, et une insuffisance cardiaque."
}
},
{
"@type": "Question",
"name": "Quels effets secondaires des médicaments cardiaques ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure des vertiges, des nausées, et des troubles de la vision."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque cardiaque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'hypertension, le diabète, le tabagisme, et l'obésité."
}
},
{
"@type": "Question",
"name": "Quel rôle de l'âge dans les maladies cardiaques ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le risque de maladies cardiaques augmente avec l'âge en raison de l'usure des vaisseaux sanguins."
}
},
{
"@type": "Question",
"name": "Comment le cholestérol affecte-t-il le cœur ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un taux élevé de cholestérol LDL augmente le risque de maladies cardiaques et d'AVC."
}
},
{
"@type": "Question",
"name": "Quel impact du diabète sur le cœur ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diabète augmente le risque de maladies cardiaques en endommageant les vaisseaux sanguins."
}
},
{
"@type": "Question",
"name": "Comment le stress influence-t-il le cœur ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress chronique peut augmenter la pression artérielle et le risque de maladies cardiaques."
}
}
]
}
]
}
Epidermal growth factor receptor (EGFR), a receptor tyrosine kinase, is activated by ligand binding, overexpression, or mutation. It is well known for its tyrosine kinase-dependent oncogenic activitie...
We report a novel method to inhibit epidermal growth factor receptor (EGFR) signaling using custom morpholino antisense oligonucleotides (ASOs) to drive expression of dominant negative mRNA isoforms o...
Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer type, has often an aggressive course and is poorly responsive to current therapeutic approaches, so that 5-year survival r...
The epidermal growth factor receptor (EGFR) is expressed robustly in the placenta, and critical processes of pregnancy such as placental growth and trophoblast fusion are dependent on EGFR function. H...
The epidermal growth factor receptor (EGFR) triggers the activation of many intracellular signals that control cell proliferation, growth, survival, migration, and differentiation. Given its wide expr...
Being the most common cause of acute viral hepatitis with >20 million cases per year and 70,000 deaths annually, HEV presents a long-neglected and underinvestigated health burden. Although the entry p...
Here we identify the EGF receptor (EGFR) as a novel host factor for HEV and reveal the significance of EGFR for the HEV entry process. By utilizing RNAi, chemical modulation with Food and Drug Adminis...
Taken together, our study provides novel insights into the life cycle of HEV and identified EGFR as a possible target for future antiviral strategies against HEV....
Dysregulation of epidermal growth factor receptor (EGFR) is one of the most common mechanisms associated with the pathogenesis of various cancers. Mitogen-inducible gene 6 [MIG6; also known as ERBB re...
Odontogenic cysts and tumors develop from the dental follicle of asymptomatic impacted teeth. Odontogenic tissues express the epidermal growth factor receptor family (EGFR), which mediates cell prolif...
In this analytical study, immunohistochemical staining of EGFR and HER2 was performed on 30 normal and 30 abnormal follicles of impacted third molars. Follicles with a width of <2.5 mm were considered...
The EGFR and HER2 overall expression was high in all normal and abnormal follicles. The comparison of the percentage of stained cells and intensity of EGFR and HER2 staining in normal and abnormal fol...
Due to the high expression of EGFR and HER2 in normal and abnormal follicles, as well as the lack of significant differences in these two groups, the radiographic size of dental follicles might not in...
Activation of the epidermal growth factor receptor (EGFR) pathway is involved in the pathogenesis of asthma. Although decades of intensive research have focused on the role of EGFR in asthma, the spec...
Acquired resistance to anti-epidermal growth factor receptor (EGFR) inhibitor (EGFRi) therapy in colorectal cancer (CRC) has previously been explained by the model of acquiring new mutations in...
We analyzed paired plasma samples from patients with...
Patients whose tumors were treated with and responded to EGFRi alone were more likely to develop acquired mutations (46%) compared with those treated in combination with cytotoxic chemotherapy (9%). F...
These findings support a model of resistance whereby transcriptomic mechanisms of resistance predominate in the presence of active cytotoxic chemotherapy combined with EGFRi, with a greater predominan...